We are live on ! Find out more
CLRB icon

Cellectar Biosciences
CLRB

43 hedge funds and large institutions have $14.9M invested in Cellectar Biosciences in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

0.02% less ownership

Funds ownership: 0.1% → 0.08% (-0.02%)

2% less funds holding

Funds holding: 44 → 43 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

39% less capital invested

Capital invested by funds: $24.2M → $14.9M (-$9.35M)

Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
16
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$334K
2
PAM
PVG Asset Management
Colorado
+$265K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$221K
4
State Street
State Street
Massachusetts
+$214K
5
QI
QS Investors
New York
+$206K

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$3.52M
2
SCM
Silverarc Capital Management
Massachusetts
-$976K
3
Two Sigma Investments
Two Sigma Investments
New York
-$588K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$425K
5
Millennium Management
Millennium Management
New York
-$397K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$32K +$6.07K +14 +18%
Osaic Holdings
27
Osaic Holdings
Arizona
$28K +$23.4K +54 +216%
MSAM
28
Moloney Securities Asset Management
Missouri
$22K +$26.9K +62 New
QP
29
Quilter Plc
United Kingdom
$20K +$24.7K +57 New
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$18K +$7.37K +17 +52%
ECM
31
ExodusPoint Capital Management
New York
$17K -$10.8K -25 -34%
PFS
32
Prospera Financial Services
Texas
$17K – – –
UBS Group
33
UBS Group
Switzerland
$14K +$13.4K +31 +443%
PNC Financial Services Group
34
PNC Financial Services Group
Pennsylvania
$12K – – –
TCM
35
Tradewinds Capital Management
Washington
$12K – – –
Bank Julius Baer & Co
36
Bank Julius Baer & Co
Switzerland
$9K – – –
HI
37
Harbour Investments
Wisconsin
$9K +$1.3K +3 +13%
JFGIW
38
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$7K +$1.3K +3 +20%
Wells Fargo
39
Wells Fargo
California
$4K – – –
US Bancorp
40
US Bancorp
Minnesota
$3K – – –
CAPTRUST Financial Advisors
41
CAPTRUST Financial Advisors
North Carolina
$2K – – –
Rockefeller Capital Management
42
Rockefeller Capital Management
New York
$1K +$1.3K +3 New
SCM
43
Sio Capital Management
New York
– -$3.52M -7,294 Closed
SCM
44
Silverarc Capital Management
Massachusetts
– -$976K -2,021 Closed
Millennium Management
45
Millennium Management
New York
– -$397K -822 Closed
Squarepoint
46
Squarepoint
New York
– -$220K -456 Closed
Charles Schwab
47
Charles Schwab
California
– -$37K -76 Closed
Dimensional Fund Advisors
48
Dimensional Fund Advisors
Texas
– -$34K -71 Closed
SFS
49
Sowell Financial Services
Arkansas
– -$24K -59 Closed
TRCT
50
Tower Research Capital (TRC)
New York
– -$25K -51 Closed
1
2
3

CLRB Hedge Fund Activity: Q2 2021 in Review

43 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q2 2021, worth a combined $14.9M — down 39% from $24.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of CLRB and 9 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 16 added.

The largest buyer was Vanguard Group, adding an estimated $334K. The largest seller was Sio Capital Management, exiting entirely with an estimated $3.52M sold.

  • 43 institutional investors held Cellectar Biosciences (CLRB) as of Q2 2021, down from 44 in Q1 2021.
  • Funds reported $14.9M of Cellectar Biosciences stock for Q2 2021, down 39% quarter-over-quarter.
  • 9 funds opened new Cellectar Biosciences positions in Q2 2021 and 10 closed out, a net change of -1 holder.
  • The largest Cellectar Biosciences buyer in Q2 2021 was Vanguard Group, an estimated $334K added.
  • The largest Cellectar Biosciences seller in Q2 2021 was Sio Capital Management, an estimated $3.52M sold.

Based on aggregated 13F filings for Q2 2021.